Asia faces formidable healthcare challenges. An ageing population combined with longer life expectancy, as well as changing diets and lifestyles, are dramatically altering the region’s health profile. The surge in age-related healthcare requirements, and in the incidence of non-communicable diseases has put an additional burden on healthcare systems already struggling to cope. Governments have responded by increasing budgetary spending on healthcare infrastructure and services, and opening the door wider to private investment.
This has provided business opportunities for global and local healthcare and pharmaceuticals companies. But the huge healthcare market comes with challenges: poor distribution, lack of skilled personnel, pricing conundrums and constraining regulations, among others. Asia’s governments are adapting national healthcare policies to allow the private sector to share their healthcare load, but are mindful that they alone remain responsible for providing citizens with access to at least basic healthcare.
How governments in Asia maintain this balance while addressing the push-and-pull of supply and demand, and how the private sector both improves and benefits from a transforming healthcare landscape is the theme of FT Asia Healthcare & Life Sciences Summit: Shaping the future of healthcare. Chief executive officers, chief medical officers and other senior business and government leaders will examine how initiatives taken today will change the healthcare geography for tomorrow.